$595.940.89%-5.38
United Therapeutics Corp (UTHR)
Date: 2026-11-04 16:00O: 583.63H: 614.23L: 578.28C: 610.43Vol: 564.5k
United Therapeutics Corp (UTHR) 재무 분석
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|---|
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues | 0.23%783.30 | 781.50 | 790.20 | 799.50 | 798.60 |
| Cost Of Revenue | 25.41%99.50 | 133.40 | 103.40 | 100.90 | 87.60 |
| Gross Profit | 5.51%683.80 | 648.10 | 686.80 | 698.60 | 711.00 |
12.28%206.70 | 184.10 | 190.60 | 182.60 | - | |
| Selling, General, and Administrative | 12.28%206.70 | 184.10 | 190.60 | 182.60 | - |
| Research and Development | 5.86%146.30 | 138.20 | 139.50 | 127.50 | - |
| Costs And Expenses | 0.70%452.50 | 455.70 | 433.50 | 411.00 | 434.10 |
| Operating Income/Loss | 1.53%330.80 | 325.80 | 356.70 | 388.50 | 364.50 |
| Nonoperating Income/Loss | 658.67%41.90 | -7.50 | 87.30 | 49.50 | 43.90 |
| Income/Loss From Continuing Operations Before Tax | 17.09%372.70 | 318.30 | 444.00 | 438.00 | 408.40 |
| Income Tax Expense/Benefit, Deferred | 0.77%25.70 | 25.90 | - | - | - |
| Income Tax Expense/Benefit | 8.53%39.70 | 43.40 | 79.70 | 99.30 | 98.90 |
21.13%333.00 | 274.90 | 364.30 | 338.70 | 309.50 | |
| Attributable To Parent | 21.13%333.00 | 274.90 | 364.30 | 338.70 | 309.50 |
| Basic Average Shares | 2.07%42.60 | 43.50 | - | 43.80 | 45.10 |
| Diluted Average Shares | 2.97%45.80 | 47.20 | - | 47.30 | 48.30 |
| Basic Earnings Per Share | 23.73%7.82 | 6.32 | - | 7.73 | 6.86 |
| Diluted Earnings Per Share | 24.91%7.27 | 5.82 | - | 7.16 | 6.41 |